matrix hormones semaglutide Treatment with semaglutide, a GLP-1 receptor agonist, improves extracellular remodeling in the pancreatic islet of diet-induced obese mice Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

The burden of hypercholesterolemia and ischemic heart disease in an ageing world

In a randomized, double-blind, breast cancer prevention trial (NSABP P-1 trial), infection/sepsis (6% vs 5.1%) occurred more often in women at high risk for developing breast cancer who received 5 years of tamoxifen therapy (n = 6492) compared with placebo (n = 6484)

Compared with placebo, semaglutide produced clinically meaningful improvements: Average weight loss of just over 11 kg Average reduction in BMI of around 3.6 kg/m Average reduction in HbA1c of 0.37 percentage points Significant improvements in fasting glucose levels These were rated as high- or moderate-certainty findings

Bacteriostatic water is a versatile reliable, and effective tool for medication preparation

Journal of Pediatric Gastroenterology and Nutrition

A mechanism of action of metformin in the brain: prevention of methylglyoxal-induced glutamatergic impairment in acute hippocampal slices